Hungary vs Latvia: Cause of death, by non-communicable diseases, ages 0-4, male
Hungary
39.1%
in 2021
Latvia
38.9%
in 2021
Hungary rank
51st
Latvia rank
52nd
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Hungary
- Latvia
How they compare
Hungary currently reports 39.1% against 38.9% in Latvia, a difference of 0.2%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Latvia ahead.
Hungary ranks 51st and Latvia ranks 52nd of 185 countries.
Across the 3 decades both report, Hungary averaged higher in 2 and Latvia in 1.
Head to head by decade
| Decade | Hungary | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.5% | 41.3% | 8.9% | Latvia |
| 2010s | 39.6% | 37.9% | 1.7% | Hungary |
| 2020s | 40.1% | 39.4% | 0.7% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Hungary or Latvia?
- Hungary, at 39.1% against 38.9% in Latvia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Hungary and Latvia?
- 0.2%, with Hungary ahead.
- How many years of comparable data are there for Hungary and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Hungary and Latvia rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Hungary ranks 51st and Latvia ranks 52nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.